Some studies suggest that fetal sex plays a role in maternal physiological processes during pregnancy including glycemic control, blood pressure, and cortisol regulation. However, data examining fetal sexspecific differences in maternal immune parameters is lacking. In the current study, serum levels of interleukin(IL)-6, IL-8, and tumor necrosis factor(TNF)-a as well as LPS-stimulated production of IL-6, IL-8, TNF-a, and IL-1b by PBMCs incubated for 24 h were assessed in early, mid, and late pregnancy among 80 women (46 with male and 34 with female fetuses). Linear mixed models showed that women carrying females versus males exhibited greater stimulated production of IL-6 at each timepoint (ps 6 0.03), TNF-a in early pregnancy (p = 0.04), and IL-1b in mid-and late pregnancy (ps 6 0.05). Despite changes in serum levels of IL-8 (p = 0.002) and TNF-a (p < 0.0001) across pregnancy, no differences in any serum cytokines were observed in relation to fetal sex (ps > 0.85). In conclusion, in pregnant women, those carrying female versus male fetuses exhibited greater stimulated cytokine production across pregnancy. Differential inflammatory responses could affect maternal health and fetal development. Fetal sex should be considered as a factor in studies of maternal inflammation. These findings have relevance both clinically and conceptually. For example, maternal asthma is exacerbated among women carrying female versus male fetuses. In addition, data on associations between fetal sex and maternal immune function among women with health conditions (e.g., preeclampsia) and adverse pregnancy outcomes (e.g., preterm birth) would be informative.
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Introduction
Pregnancy is characterized by substantial changes in maternal immune parameters. Pregnant women exhibit heightened serum levels of certain proinflammatory cytokines as well as greater lipopolysaccharide (LPS) stimulated proinflammatory cytokine production than non-pregnant adults (e.g., Brewster et al., 2008; Vassiliadis et al., 1998) . Although limited, longitudinal examinations have demonstrated significant increases in some serum and LPS-stimulated cytokines across pregnancy, including serum TNFa, stimulated IL-6, and stimulated IL-1b, while other markers exhibit a decline, such as serum IL-8 (Christian and Porter, 2014; Gillespie et al., 2016) . Information regarding factors which may modify such adaptation is limited.
Bidirectional communication between the pregnant woman and fetus has been supported, with fetal sex shown to play a role (Glynn and Sandman, 2011) . Specifically, though not found in all studies, some studies have shown that fetal sex is associated with differences in maternal physiology, including cortisol regulation, glycemic control, and blood pressure (DiPietro et al., 2011; Giesbrecht et al., 2015; Hocher et al., 2009; Petry et al., 2007) . Studies examining associations between fetal sex and maternal immune parameters are limited. However, some studies have shown differences by fetal sex in immune-relevant gene expression as well as cytokine expression in the placenta, with women carrying female fetuses compared to males showing elevated levels (Clifton and Murphy, 2004; Scott et al., 2009) . Data examining whether fetal sex is associated with distinct patterns in maternal inflammatory processes as measured in peripheral blood is lacking.
